Laboratório Lustosa has been sold to DASA

Laboratório Lustosa

Laboratório Lustosa is a leading provider of lab diagnostic solutions in Minas Gerais, Brazil, offering a wide range of testing solutions to more than 300,000 patients annually. Lustosa’s portfolio is made up of laboratorial, genomic and COVID-19 exams, as well as vaccination services, which are offered through its 26 units and home care.

The Deal

Lustosa’s more than 330 employees will now join DASA, the largest integrated healthcare network in Brazil, with a portfolio comprising more than 60 brands of laboratories, hospitals and medical centers. The acquisition follows DASA’s strategy of expanding its diagnostics operations and strengthening its presence in the state of Minas Gerais, where DASA will have more than 80 units.

Our Perspective

Luiz Recchia, Managing Director in Lincoln’s São Paulo office, commented, “Lustosa now joins the DASA system and its patients will greatly benefit from a wider range of products and services. With the acquisition, DASA becomes the undisputed leader in one of the best locations in Brazil, and benefits from the exceptional quality of services that Lustosa provides.”

DASA

DASA is the largest integrated healthcare network in Brazil, with more than 40,000 employees allocated in more than 900 units and currently serving more than 20 million people annually. DASA is present in all healthcare stages and operates from a preventive, predictive and personalized point of view. With more than 59 brands of diagnostic medicine and hospitals, DASA believes in a healthcare journey that integrates diagnostic medicine, high-complexity hospitals, genomics, oncology, care coordination, primary and secondary care, telemedicine and emergency care.

Share: